Attention Deficit Disorders

[P050] A 14 Week, randomized, placebo-controlled cross-over study of multilayer release methylphenidate capsules (PRC-063) in adult ADHD with and without anxiety disorder comorbidity

*Nisha Ravindran¹, Michael Van Ameringen², Beth Patterson³, Juliette Mojgani⁴, J. Turna⁵, C. Goldman Bergman⁶, Angela Paric⁷, Annette Kowara⁸, Arun Ravindran⁹ (1. University of Toronto, 2. McMaster University, 3. McMaster University , 4. McMaster University , 5. McMaster University , 6. McMaster University , 7. University of Toronto , 8. University of Toronto , 9. University of Toronto )

Keywords:Attention-Deficit Hyperactivity Disorder, Anxiety Disorders, Stimulants, ADHD